704550

QUANTA Lite® CCP3.1 IgG/IgA

This assay is designed for the detection of anti-CCP3 IgG and IgA antibodies in patient sera, citrated or EDTA plasma. The presence of these antibodies can aid in the diagnosis of rheumatoid arthritis (RA), including RA diagnosed within 2 years of presentation of symptoms.

request more information
IVD-In Vitro Diagnostic Use / CE marked
Technology
ELISA
CLIA complexity
High
Package Size
1 X 96 wells
Disease Area Application
Rheumatoid Arthritis (RA)
Antigen Source
Synthetic peptide
View reagents
Contact Us

Contact us directly using the below, or by filling out the form.

Tel: 01925 810 141 - Option 6

 

Tel: 0800 102 6342

 

Tel: 01925 810 141 - Option 1

DATA PROCESSING NOTICE:

Werfen Ltd will process your personal data to respond to your requests for information or support, or to understand your needs and provide you with a better service relying on our legitimate interest to do so. You can find more information about our data privacy practices and how to exercise your rights in our Privacy Policy. You can also contact us at DPO-uk@werfen.com.